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Background: The extent of treatment for differentiated thyroid cancer remains controversial. The objective of this
study was to describe the variations in practice prior to diagnosis and for the first year after diagnosis, including the
investigations, the extent of surgery and the use of RAI 131, for all patients with thyroid cancer (TC) treated Jan 1
2000 to Dec 2008 across Ontario Canada.
Method: Population-based study of all patients who had a therapeutic surgical procedure for TC based on the data
holdings of the Institute of Clinical Investigative Sciences (ICES) linking the Ontario Cancer Registry to the Ontario
Health Insurance Plan and to the Canadian Institutes of Health Information. The analysis includes comparisons
between health care utilization/geographic regions and between treating specialties. The study population was
12957 patients.
Results: There was a 112% increase in case detection over 9 years. Overall the initial (index) surgery was less-than-total
thyroidectomy (LTT) in 37.6% and 63.4% of the patients who had total thyroidectomy (TT) as an index surgery went on
to adjuvant RAI, however there was wide variation in all aspects of patient care across the province, between Local
Health Networks and between surgical specialties.
Conclusion: In Ontario, there was wide variation for most aspects of the management of TC and, as the incidence of
TC is increasing at least 7% per year in females, these data provide a foundation for future discussions, the provision of
health care services and research.
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When doctors are uncertain and there is a lack of con-
sensus on best treatment, practice will vary [1,2]. As
there is no randomized control trial evidence for any as-
pect of the treatment of differentiated thyroid cancer,
the treatment decisions on the extent of both surgical
and use of post operative radio active iodine 131 (RAI)
remain controversial [3,4] and treatment is known to
vary. In the absence of evidence, a first step towards dis-
cussion and consensus is to understand current practice
and the objective of this project was to describe the
management and the variation in the management of* Correspondence: sfh@queensu.ca
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unless otherwise stated.patients with thyroid cancer from Ontario Canada dur-
ing their first year after diagnosis based on a complete
unbiased patient population.Methods
Study population and data sources
We identified all patients over 18 years of age with a
diagnosis of thyroid cancer (ICD 193) in the Ontario
Cancer Registry (OCR) between Jan 1 1999 and Dec 31
2008 who had a surgical procedure for thyroid cancer
between Jan 1 2000 and Dec 31 2008 (n = 13724). The
OCR is a population-based tumor registry operated by
Cancer Care Ontario and consists of linked data on all
patients with cancer including demographic information
from all cancer treatment centers and all pathology re-
ports of cancer from all hospitals and laboratories. This. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ative Sciences (ICES) to physician billing codes and dates
of treatment or testing (surgery, diagnostic radiology,
radioactive iodine, and fine needle aspirate biopsy (FNAB))
in the Ontario Health Insurance Plan (OHIP) administra-
tive database and to hospital procedure codes and dates
of treatments (surgery, in-patient radioactive iodine) in
the Canadian Institutes of Health Information (CIHI)
databases. We used the CIHI hospital procedure codes
as our primary data source for extent of surgery. We
compared the CIHI hospital procedure codes to the
OHIP surgical billing codes, compared the sequences of
codes, assigned an initial index surgery to each patient
and excluded 769 cases due to discrepancy on the ex-
tent of the index surgery, incomplete information or
incompatible codes. Patients with biopsies, nodulect-
omy or other non- therapeutic procedure were excluded.
Hemithyroidectomy and subtotal thyroidectomy were
combined as “less than total thyroidectomy” (LTT) to
compare with total thyroidectomy (TT). The date of diag-
nosis for each patient was the date of the index surgery
and the sequence of treatment for each patient included
index surgery, completion surgery, subsequent surgery
(after completion or total thyroidectomy), neck dissection
(any neck dissection billing code) and first radioactive iod-
ine ablation (RAI) within the first year after the index sur-
gery. Histological subtypes for this study as assigned at the
OCR included differentiated (papillary and follicular), me-
dullary and other (insular and anaplastic). The study
population was 12,959 patients treated with an index sur-
gical procedure for thyroid cancer. The same dataset was
used for a previous publication Access, Excess and Over-
Diagnosis: the case for thyroid cancer [5].
Health care services in the Province of Ontario Canada
are divided into 14 geographic regions (Local Health
Integration Networks (LHINs)) (Figure 1) based on health-
care utilization as well as political boundaries. Toronto is
the largest city in the Province of Ontario and the GreaterFigure 1 LHINs of Ontario.Toronto Area (GTA) is within LHINs 5, 6, 7, 8 and 9.
These LHINs also include communities outside and sur-
rounding the GTA.
Ethical approval
This study was approved by the ICES Cancer Program and
the Queen’s University Research Ethics Board #OTOL-041-10.
Analysis
We calculated the mean rates of diagnosis per 100,000
(the total number of cases for 8 years for the total popu-
lation of those years) and compared them by LHIN. The
95% confidence intervals are based on the mean of the
rates over the 9 years assuming a Poisson distribution.
There were a small number of cases per year in some
LHINs and because we used the rates based on the aver-
age over 9 years, age and gender adjustment was not
practical. We examined the age and gender indirectly
standardized incidence ratios for each LHIN compared
to the population of all Ontario in 2004 and found that
the adjusted ratios reflected the actual rates.
There is no restriction in Ontario on where patients can
be treated. Referral patterns can be variable, resources vary
and it is common practice for patients to receive treatment
outside of their LHIN of residence. To understand the pat-
terns of practice we therefore report the LHIN of the pa-
tient’s residence to compare rates of diagnosis and report
the both LHIN of the treatment and LHIN of residence to
describe and compare the variability of practice.
Results
Overall
Eighty percent of patients were female and the average
age for females was 47.1, 3.5 years younger than males.
Papillary and follicular carcinoma accounted for 98.0% of
cases with a histological diagnosis code noting that the
code in the OCR was missing for 6.3% of cases (n = 815).
There were only 184 cases of Medullary carcinoma and 57
cases of Anaplastic/Insular carcinoma over the 9 years.
The number of cases per year increased from 893 to
1890 per year creating an overall increase of 112% (Figure 2)
due to a rate increase from 10.19/100,000 to 18.89/100,000
across Ontario over the 9 years. There was a wide vari-
ation across the Province in the rate of diagnosis of inci-
dent cases by LHIN (Figure 3) with some of the GTA
LHINs having diagnosis rates up to 4 times greater than
other regions of the province. With the indirect age/
gender standardized adjustment the rank order of the
LHINs on Figure 3 did not change.
Investigations
FNAB
79% of patients had at least one FNAB prior to index
surgery and this proportion stayed constant over the
Figure 2 New cases per 100,000 by year in Ontario.
Figure 4 Rate of Neck Ultrasounds vs Detection of Thyroid
Cancer by LHIN.
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per year in Ontario with increasing incidence of thyroid
cancer. Patients over 70 years of age had fewer FNAs
and patients with differentiated thyroid cancer had more
FNABs than the other histological types (p = 0.001).Diagnostic ultrasound
With the progressive rise in the rate of diagnosis of
thyroid cancer, the rates of diagnostic ultrasound of
the neck for the general population increased across
the Province from 681/100,000 to 1477/100,000 over
the 9 years. Figure 4 compares the rates of detection
by LHIN to rates of diagnostic ultrasound of the neck
by LHIN. For Figure 4, the thyroid cancer cohort was
excluded and only one ultrasound per person was
counted. The relationship is very clear with differences
in physician behaviour for ordering ultrasound imag-
ing in different LHINs creating differences in rates of
diagnosis (r = 0.91).Figure 3 Diagnosis rate (per 100,000) over 9 years by LHINs.Index surgery
The index (initial) surgery was LTT for 37.6% (4864) and
TT for 62.4% (8095) of cases. A neck dissection at the
time of index surgery was recorded in 14.9% of cases
(n = 1931). Almost all patients with medullary and ana-
plastic/insular carcinoma had total thyroidectomy.
There were large variations in the extent of index sur-
gery across Ontario. Figure 5 presents the rates of TT
when the index surgery (29% to 82%) performed in the
various LHINs across Ontario. There was substantial
across-LHIN patient migration for surgery (33% of all
Ontario patients had surgery outside of their residence
LHIN and 40.5% of patients living in a GTA LHIN had
surgery in another GTA LHIN) resulting in 28% of
LHIN 6 surgical cases migrating in from another LHIN
yet only 28% of the thyroid cancer patients who lived in
LHIN 8 had their surgery in LHIN 8.
Figure 5 Extent of index thyroid surgery: % of patients with total thyroidectomy based on treatment LHIN.
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Overall 57.0% of the initial index surgical cases were
done by Otolaryngologist/Head and Neck Surgeons and
42.7% by General Surgery/Thoracic Surgery (34 un-
known). Figure 6 compares the extent of index surgery
by both specialty and by LHIN, with the LHINs ranked in
the order of thyroid cancer detection (Figure 3). There
were large differences in the extent of index surgeryFigure 6 Extent of initial surgery: % of cases having total
thyroidectomy by specialty by LHIN of treatment.between the surgical specialty groups with a pattern of TT
being done more commonly by Otolaryngologists in re-
gions of higher thyroid cancer detection.Subsequent surgery
54.2% of the 4864 patients who had a LTT procedure as
index surgery went on to completion thyroidectomy
whereas only 18 of the 8085 patients (0.002%) who had
TT as index surgery had a subsequent surgery on thy-
roid or neck in the first year.Radioactive iodine ablation
The practice of adjuvant RAI, similar to the extent of
surgery, varied across the Province. Based on patient ad-
dress the range of use of post operative RAI varied from
46.1 - 66% (Figure 7) with the highest rates in some of
the LHINs with the highest incidence and the highest
rates of TT. Due to differences in treatment resources
there was considerable patient migration such that the
number of cases treated by each LHIN varied from zero
(LHINs 3 and 12 had no facility) to 3305 (LHIN 7), with
3 LHINs treating 600-1000 patients and 8 treating 100-
400 patients over the 9 years. The large number of cases
treated in LHIN 7 corresponds to the 50 RAI specialists
who treated the patients, whereas the other LHINs had
1-11 RAI specialists. Higher numbers of RAI physicians
Figure 7 Cases treated with RAI: % of patients who had total thyroidectomy as index surgery by patient LHIN.
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not consistent across the province.
RAI can be given as inpatient or as outpatient treat-
ment noting that inpatient RAI may be a surrogate for
dose as well in some jurisdictions. Figure 8 presents the
RAI regimens by LHIN based on treatment location and
regimens also varied by LHIN with 10.3% –91% of pa-
tients having in-patient treatment.
Overall 63.4% of the patients having TT as an index
surgery and 77.6% of those who had a completion pro-
cedure following less-than-total thyroidectomy went on
to have RAI.Figure 8 RAI practice by treatment protocol: % In-patient vs %
Out-patient RAI based on LHIN of treatment.Radioactive iodine practitioners
Figure 9 demonstrates the variation in specialists treat-
ing patients with RAI by LHIN. 53.9% of RAI cases
were billed by Internal Medicine Specialists (including
Endocrinologists), 27.1% by Radiologists (including Diag-
nostic and Nuclear Medicine) and 6.97% by Radiation
Oncologists (7.6% other and 4.4% missing).
Overall treatment sequence
Table 1 summarizes the treatment sequence in the first
year. 17.2% of patients had LTT only, 27.1% had TT, andFigure 9 Physician specialty for RAI treatment: % of cases
treated by specialty based on treatment LHIN.
Table 1 Sequence of treatment over first year for all
patients
% cases
Non-total thyroidectomy alone 17.2
Non-total thyroidectomy with completion 4.3
Non-total thyroidectomy with completion and RAI 15.9
Total thyroidectomy alone 22.8
Total thyroidectomy with RAI 39.6
(100)
Non-total thyroidectomy only 17.2
All total thyroidectomy without RAI 27.1
All total thyroidectomy with RAI 55.5
(100)
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erable differences between LHINs with ranges for LTT
(11% - 25%) and TT only (18% - 32%).
Discussion
The objective of this project was to create the knowledge
foundation on current practice that could be used for
informed discussions on the management of thyroid
cancer. We found wide variation in all aspects of care in-
cluding the use of diagnostic tests, initial surgical treat-
ment and RAI treatment along with significant variation
in the physician specialties providing care for this group
of patients. Overall we found a 4 fold difference in rate
of diagnosis by LHIN that correlated with the differences
in the use of diagnostic ultrasound of the neck. We con-
firmed that trans-LHIN patient migration and out-of-
region referral patterns were common for both surgery
and RAI. We determined that TT was performed more
often than LTT in the LHINs of the Greater Toronto re-
gion compared to the rest of the province of Ontario
and that TT was performed more often by otolaryngolo-
gist/head and neck surgeons compared to general sur-
geons. Similarly RAI was given in different regimens by
different specialty physicians across the province. These
data confirm that in Ontario there is no agreement on
most aspects of the management of TC and as the diag-
nosis of thyroid cancer is increasing in females, there is
an urgent need for policies on extent of surgery and the
use of RAI for physicians, patients and the funders of
health care systems. Policies however have to be based
on evidence not merely consensus, and the further re-
search, based on our identified variations, could generate
downstream evidence on the impact of tests and treat-
ments such as further tests, outcomes (relapse, further
treatments, further tests, survival) and costs.
The strength of this study is the complete dataset of
all patients with TC due to the universal health care inthe Province of Ontario, the legislated collection of data
from multiple sources on all patients and the availability
of centralized administrative datasets.
The limitation of this study is the lack of data on ex-
tent of disease. Unlike the SEER dataset in the United
States, neither tumor size nor stage for thyroid cancer
are available electronically in the Ontario Cancer Registry.
Our report is similar to the ICES Surgical Atlas
[6] – a description of treatments by regions without extent
of disease. There is however no reason to suspect that
there are wide differences in the proportions of histo-
logical types or extent of disease across the LHINs - in
particular in the numbers of cases with poorer prognosis
cancers. There is no reason to suspect that the vast major-
ity of cases are not small papillary cancers. One potential
weakness of the study is the reliability of the extent of sur-
gery data and we used two strategies to reduce error. First
we used the hospital procedure codes as our primary data.
The CIHI and OHIP datasets have excellent agreement
for the coding of common surgical procedures [7] but
the reliability for TC surgery is not known and the
OHIP fee schedule may not reflect some scenarios.
Our second strategy to reduce error as well as any po-
tential bias in the codes was to re-examine all patients
with non-matching codes and incompatible sequences
before deletion.
Practice patterns are often estimated by surveys and
the surveys based on case scenarios about practice pat-
terns in thyroid cancer management support our find-
ings on non-agreement and treatment variation. For
example, Wu et al. [8] reported the results of a survey of
438 thyroid cancer surgeons in the United States on ex-
tent of surgery in a low-risk case scenario when the pa-
tient had had a hemithyroidectomy. They found 29.7%
of surgeons would perform a completion thyroidectomy.
Using multiple variable analysis, they found geographic
region, case volume and specialty drove more extensive
treatment with otolaryngologists more aggressive than
general surgeons. Interestingly higher case volume was
associated with less aggressive surgery. They concluded
that the surgical treatment of papillary micro-carcinoma
was inconsistent across different regions and dependent
on surgeon’s training. Similarly Sawka et al. [9] reported
the results of a survey of 486 thyroid cancer specialists
in Canada and the United States on the use of RAI in a
specific low-risk clinical case scenario. They found no
agreement on the indications for treatment across differ-
ent geographic regions even when the risk level of the
case scenario was increased. They reported for the low-
risk case scenario that non-university affiliation and
physician specialty predicted a stronger recommendation
for treatment. Van den Bruel et al. [10] reported a survey
of thyroidologists in Belgium. The case of a 3 cm FNA
suspicious nodule would have been treated with total
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agreement on extent of neck dissection despite the nega-
tive ultrasound. When the nodule was reduced to 0.9 cm
low risk case there still was no agreement. Finally Parks
et al. [11] reported a survey of Canadian otolaryngolo-
gists about the management of a case of micropapillary
carcinoma. They found 97% of surgeons would do a total
thyroidectomy for tumor < 1 cm although there was no
agreement on extent of neck dissection. They noted the
ATA Guideline for the case was that the patient “may be
treated with lobectomy”. These 4 surveys confirm the
lack of agreement and identify factors such as geograph-
ical regions and specialist type similar to our data.
Our findings are consistent with other population-
based research literature on practice patterns in thyroid
cancer management. Haymart et al. [12] for example,
utilized the US National Cancer Database dataset with
189,219 patients with DTC between 1990 and 2008 to
study practice patterns for RAI across the US. They
found an increasing use of RAI over time for patients
after TT. The variables associated with increased use
included age (younger), comorbidity (healthier), stage
(increasing stage) and increasing hospital case volume.
The variables associated with decreasing use were race
(African-American), insurance (absence of) and gender
(female). They report a complex analysis demonstrating
that only small proportions of the variance in practice
could be explained by age, gender, race, comorbidity,
poverty, insurance, education, rurality, stage, case vol-
ume and hospital type. Curiously they found the high
unexplained variance extending to include groups such
as low-risk younger females with small tumors and older
males with larger tumors where indications might have
been clearer. They concluded that there was clinical
uncertainty on the indications for RAI, that extent of
disease did not seem to drive treatment and that over-
treatment needed to be considered because of the poten-
tial for treatment-induced toxicity and late side effects.
Similarly Panigrahi et al. [13] used the SEER dataset to
examine the national practice pattern for medullary thy-
roid cancer between 1988 and 2006. They identified
2033 cases and compared their treatments to the ATA
guideline published in 2009. They found statistically
significant differences in the extent of treatment in dif-
ferent geographic regions of the United States (South,
Midwest, Northeast and West) when controlling for
tumor size and tumor extent. Both the population based
studies found complex relationships with practice.
Variations in the management of other head and neck
cancers have been reported within Ontario and compared
to Ontario. For example, the treatment of hypopharyngeal
cancer for example varied during 1990-2000 across the 8
cancer treatment centers with between-center differences
of 85% to 42% having primary radiotherapy and 2% to43% having primary surgery [14]. Similarly large variations
in the use of radiotherapy versus primary surgery have
been documented between Ontario and the United States
in laryngeal cancer [15,16]. Variations in rates of diagnosis
and extent of treatment for other cancer sites have been
comprehensively described for the Province of Ontario in
the ICES Atlas of Cancer Surgery (2008) [6]. This Atlas
described cancer diagnosis and surgery for 31,457 patients
with breast, colon, prostate, lung and gynaecological can-
cers by LHIN from April 1 2003 to March 31 2004. The
objectives of the Atlas were to support regional planning,
provide a background for research and improve quality of
care. Between-LHIN variations in rates of diagnosis ap-
proaching 2-fold were noted in breast, prostate and lung
cancer. This study on thyroid cancer has confirmed a 4-
fold difference in rate of diagnosis between highest and
lowest rate regions. The Atlas proposed that the differ-
ences could be related to true differences in case mix re-
lated to factors such as smoking rates, to differences in
screening or to differences in the use of diagnostic tests.
Our data suggests that differences in rates of diagnosis are
related to differences in the use of diagnostic tests [5,17]
noting that the 4-fold difference between LHINs for thy-
roid cancer diagnosis compared to the 2-fold differences
for other cancer sites could simply be explained by the
uncovering of the reservoir of undetected non-progressing
or slow growing cancers with increasing access to diag-
nostic ultrasound [18]. The Atlas reported that the age-
standardized rates of surgical management were consist-
ent across the province for breast and colon cancer, but
not for prostate and lung, and suggested that true differ-
ences in population or differences in access might be ex-
planations for the variations in practice. The extent of
surgery and the variations in the extent of those surgeries
was also reported for some cancers by LHIN such as
mastectomy with node resection for breast and for resec-
tion with permanent stoma for rectal cancer. Reasons for
the variation were postulated to include access to further
treatments, patient preference and enthusiasm of the sur-
geon. Our results for thyroid cancer show considerable
patient migration suggesting patient preference or referral
bias contribute to differences in extent of both surgery
and use of RAI.
Our finding of wide variations in practice are consistent
with the ongoing controversies in the management of TC,
the existing practice pattern literature based on surveys
and the existing practice patterns literature based on
populations. There are 4 theories, anchored by clinical
research, on treatment rate variations that might help ex-
plain these wide differences in opinion. Eddy’s Theory of
Uncertainty [2] leads from lack of consensus [1] where
uncertain physicians do not know what is right due to
poor evidence, can come to different conclusions about
the existing evidence and are often swayed local colleagues
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standards despite the poor evidence, the uncertain phy-
sicians feel safe from criticism and the standards for
the region become dogma. Eddy’s theory is about the
uncertain physician and the second theory, the theory
of Enthusiasm [19], is about the “certain” physicians.
According to Chasen, physicians who become enthusi-
asts for a particular treatment, can become blinded to
both the uncertainty and the lack of evidence and
therefore justify pushing the boundary between Appro-
priateness and Inappropriateness [20]. Appropriateness
in the management of TC, might be considered the
Guidelines of the American Thyroid Association, but
these are consensus statements by experts and clearly
Ontario physicians did not support the ATA guidelines
of the day for many patients. Chasen’s study and hy-
pothesis was based on high volume surgeons (enthusi-
asts) for carotid endarterectomy, and as we did find
large differences in practice by region as well as spe-
cialty, further research is planned to test Chasen’s the-
ory based on the Ontario data on the treatment of TC.Conclusion
There is wide variation in all aspects of the management
of thyroid cancer in many jurisdictions including Ontario
Canada. Differences in treatment produce differences in
risk and cost, and differences in rates of diagnosis have
the potential to create over diagnosis with over treatment
along with the costs of overtreatment. Evidence-based
consensus is needed in the management of this disease.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SH designed the study, assisted with the data collection, guided the analysis
and prepared the manuscript. JI advised on the analysis including clinical
aspects and revised the manuscript. PG advised on the analysis and revised
the manuscript. DU assisted with data collection and advised on manuscript.
All authors read and approved the final manuscript.
Acknowledgements
This research was conducted at ICES@Queens. The Institute of Clinical and
Evaluative Sciences (ICES) is funded by an annual grant from the Ontario
Ministry of Health and Long-Term Care. The opinions, results and conclusions
reported in this paper are those of the authors and are independent from
the funding sources. No endorsement by ICES or the Ontario Ministry of
Health and Long-Term Care is intended or should be inferred.
Funding for this project was obtained from multiple sources including the
Canadian Institutes of Health Research (MOP # 84356) and the Sullivan Chair
for Surgical Head and Neck Oncology.
The data collection and analysis was performed by Marlo Whitehead MSc
PSAT and Rebecca Griffiths at ICES@Queens. The LHIN maps were generated
by P Gozdyra at ICES. The study coordinator was Susan Rohland
We acknowledge the Ontario Cancer Registry and Cancer Care Ontario for
providing us with the Ontario Cancer Registry data used in this report as
well as the assistance of IntelliHealth Ontario.
Presented at the Canadian Otolaryngology Society May 2011, the American
Head and Neck Society July 2012 and the Canadian Surgical Forum Sept 2013Duplicate publication
Figures 2 and 3 have been published previously in Access, Excess and
OverDiagnosis: the case for thyroid cancer (Hall SF, Irish, JC, Groome PA,
Griffiths R) in the journal Cancer Medicine 2013; doi:10.1002/cam/4.184:1-8.
A brief review of the method and select results are essential to this
manuscript and meets both the copyright requirements of Wiley and the
Creative Commons Attribution Licence (http://creativecommons.org/
licences/by/3.0/).
Author details
1Departments of Otolaryngology and Oncology, Division of Cancer Care and
Epidemiology, Queen’s Cancer Research Institute, Queen’s University, 10
Stuart St. 613 533 6000 ext 78535, Kingston, ON K7L 3 N6, Canada.
2Department of Otolaryngology, Wharton Head & Neck Centre, University
Health Network, Princess Margaret Hospital, 610 University Ave., Toronto, ON
M5G 2 M9, Canada. 3Division of Cancer Care and Epidemiology, Queen’s
Cancer Research Institute, 10 Stuart St, Kingston, ON, Canada. 4Division of
General Surgery, Toronto General Hospital, University Health Network, 200
Elizabeth St, Toronto, ON M5G 2C4, Canada.
Received: 21 February 2014 Accepted: 5 July 2014
Published: 24 July 2014
References
1. Wennberg J: The Paradox of Appropriate Care. JAMA 1987, 258:2568–2569.
2. Eddy D: Variations in physician practice: the role of uncertainty. Health
Affairs 1984, 3:74–89.
3. McLeod D, Sawka A, Cooper D: Controversies the primary treatment of
low-risk papillary thyroid cancer. Lancet 2013, 381:1046–1057.
4. Sawka A, Brierley J, Ezzat S, Goldstein D: Managing newly diagnosed
thyroid cancer. CMAJ 2014, 186:269–275.
5. Hall SF, Irish JC, Groome P, Griffiths R: Access, Excess and Overdiagnosis:
the case for thyroid cancer. Cancer Med 2013, 184:1–8. doi:10.1002/cam/4.
6. Urbach D, Simunovic M, Schultz S: Cancer Surgery in Ontario: ICES Atlas.
Toronto: Institute of Clinical Evaluative Sciences; 2008. Ref Type: Report.
7. Iron K, Goel V, Williams J: Concordance With Hospital Discharge Abstracts And
Physicians Claims For Surgical Procedures in Ontario (ICES Working Paper Series
Report #42). North York (Ontario): Institute for Clinical Evaluative Sciences;
1995.
8. Wu A, Wang M, Nguyen C: Surgical Practice Patterns in he treatment of
papillary thyroid microcarcinoma. Arch Otolaryngol Head Neck Surg 2010,
136:1182–1190.
9. Sawka A, Rotstein L, Tsang RW BJ, Thabane L, Gafni A, Straus S,
Kamalanathan S, Zhao B, Goldstein DP, Rambaldini G, Ezzat S: Regional
differences in opinions on adjuvant radioactive iodine treatment of
thyroid carcinoma with Canada and the United States. Thyroid 2007,
17:1235–1242.
10. Van den Bruel A, Moreno-Reuest R, Bex M, Daumerie C, Glinoer D: Is the
management of thyroid nodules and differentiated thyroid cancer in
accordance with recent consensus guidelines? Clin Endo 2008, 68:599–604.
11. Parks N, Taylor M, Trites J, Hart R: Management of Goitre and small nodule
disease by Canadian Otolaryngologists. J Otolaryngology-Head and Neck
Surgery 2012, 41:240–245.
12. Haymart M, Banerjee M, Stewart A, Koenig R, Birkmeyer J, Griggs J: Use of
Radioactive Iodine for Thyroid Cancer. JAMA 2011, 306:721–728.
13. Panigrahi B, Roman S: Medullary thyroid cancer: are practice patterns in
the United Sates discordance from ATA Guidelines? Ann Surg Oncol 2010,
17:1490–1498.
14. Hall S, Groome P, Irish J, O’Sullivan B: Radiotherapy or Surgery for cancer of
the hypopharynx: establishing the baseline. Cancer 2010, 115:5711–5722.
15. Groome PA, O’Sullivan B: Glottic Cancer in Ontario Canada and
the SEER areas of the United States: Do different management
philosophies produce different outcome profiles? J Clin Epidemiol 2001,
54:301–315.
16. Groome P, O'Sullivan B, Irish J, Rothwell DM, Schulze K, Warde PR, Schneider KM,
Mackenzie RG, Hodson DI, Hammond JA, Gulavita SP, Eapen LJ, Dixon PF,
Bissett RJ, Mackillop WJ: Management and outcome differences in
supraglottic cancer between Ontario Canada and the SEER areas of the
United States. J Clin Oncol 2002, 21:496–505.
17. Hall S, Walker H, Seimens R, Schneeberg A: increasing detection or
increasing incidence in thyroid cancer. World J Surg 2009, 33:2567–2571.
Hall et al. Journal of Otolaryngology - Head and Neck Surgery 2014, 43:29 Page 9 of 9
http://www.journalotohns.com/content/43/1/2918. Welch G, Black W: Overdiagnosis in Cancer. J Natl Cancer Inst 2010,
102:605–613.
19. Chassin MR: Explaining geographic variations: the Enthusiasm
Hypothesis. Med Care 1993, 31:YS37–YS44.
20. Park R, Fink A, Brook R, Chassin MR, Kahn KL, Merrick NJ, Kosecoff J,
Solomon DH: Physician ratings of appropriate indications for six medical
and surgical procedures. Am J Pub Health 1986, 76:766–769.
doi:10.1186/s40463-014-0029-3
Cite this article as: Hall et al.: Practice patterns in the management of
patients with differentiated thyroid cancer in Ontario Canada 2000-2008.
Journal of Otolaryngology - Head and Neck Surgery 2014 43:29.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
